Skip to search formSkip to main contentSkip to account menu

5,10-Methylenetetrahydrofolate reductase deficiency

Known as: 5' 10' Methylenetetrahydrofolate Reductase Deficiency, 5' 10' Methylenetetrahydrofolate Reductase Deficiency (MTHFR), MTHFR 
A rare disorder associated with mental retardation, spasticity, and early death.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Betaine therapy was given for 2 years to a 2-year-old boy with 5,10-methylenetetrahydrofolate reductase deficiency. Used as a… 
Highly Cited
2003
Highly Cited
2003
Nitrous oxide irreversibly oxidizes the cobalt atom of vitamin B12, inhibiting the cobalamin-dependent enzyme methionine synthase… 
2000
2000
Hydrocephalus internus (HCI) of all four ventricles in association with early neurological abnormalities is described as the… 
1998
1998
Many authors have reported the effectiveness of betaine in the therapy of homocystinuria. However, the appropriate dose and… 
Highly Cited
1991
Highly Cited
1991
Three patients from a single family of six siblings had homocystinemia and homocystinuria due to 5,10-methylenetetrahydrofolate… 
Highly Cited
1988
Highly Cited
1988
We previously described demyelination in the brain and subacute combined degeneration of the spinal cord in a patient with 5,10… 
1985
1985
We report the case of a boy with 5,10-methylenetetrahydrofolate reductase deficiency. The clinical features consisted of severe… 
Highly Cited
1984
Highly Cited
1984
In a 3-year-old mentally retarded girl with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency among…